Rare diseases
Investigational molecules
Locations
Back to Greece973 clinical trials in Athens, Greece across 13 research sites. Every trial is listed in the EU Clinical Trials Register and updated daily.
Study on Ifinatamab Deruxtecan and Topotecan for Patients with Relapsed Small Cell Lung Cancer
GreeceStudy on Long-Term Effects of Iptacopan in Patients with C3 Glomerulopathy or Idiopathic Immune-Complex Membranoproliferative Glomerulonephritis
GreeceStudy on the Effectiveness and Safety of Vedolizumab, Budesonide, and Prednisone for Children with Moderate to Severe Crohn's Disease
GreeceStudy on the Safety of Encorafenib, Binimetinib, and Ribociclib for Patients with Solid Tumors
GreeceStudy Comparing OSE2101 and Docetaxel for Patients with Metastatic Non-Small Cell Lung Cancer After Immunotherapy Resistance
GreeceStudy of Pembrolizumab, Vibostolimab, and Chemotherapy for Patients with Newly Diagnosed Resectable Stage II-IIIB Non-Small Cell Lung Cancer
GreeceStudy on Adding Navtemadlin to Ruxolitinib for Patients with Myelofibrosis and Suboptimal Response to Ruxolitinib
GreeceStudy on Long-Term Safety of Cenerimod for Adults with Moderate-to-Severe Systemic Lupus Erythematosus
GreeceStudy of Selinexor, Dexamethasone, and Bortezomib for Patients with Refractory Multiple Myeloma
GreeceStudy of Adagrasib Alone and with Pembrolizumab for Patients with Advanced Non-Small Cell Lung Cancer with KRAS G12C Mutation
GreeceStudy on Ependymoma Treatment in Children, Adolescents, and Young Adults Using Cisplatin, Cyclophosphamide, Etoposide, and a Drug Combination
GreeceStudy of drug combinations including irinotecan, ifosfamide, vincristine, dactinomycin, regorafenib and other agents for children and adults with rhabdomyosarcoma
GreeceThe busiest research cities in the country
What the registry says about research in the country
Clinical trials focusing on head and neck cancer, bladder cancer, and advanced solid tumors. Research includes innovative combination therapies and novel treatment approaches for various tumor types.
Studies evaluate new therapeutic combinations and their impact on patient survival rates.
Investigations into treatments for various autoimmune disorders, including Sjögren's Syndrome, lupus, and inflammatory conditions.
Focus on developing targeted therapies for chronic autoimmune conditions.
Research examining treatments for heart failure, cardiovascular disease prevention, and metabolic disorders including obesity.
Trials evaluating new therapeutic approaches for cardiovascular risk reduction.
Tell us about your condition – we search every trial in Europe and connect you with the right site.
